Can’t Refuse returned positive tests to phenylbutazone and its metabolite oxyphenbutazone, an anti-inflammatory, in both pre-race and post-race blood samples taken when he ran at Sandown in July.
The gelding finished last in the 1800m race, almost 40 lengths from the winner Scholarly.
A date for the RAD Board hearing has yet to be finalised.
Credit: AAP